Monitoring Adherence Using Mobile Technology

Inclusion Criteria

• •age 6-17 years and their parents
• •either 2 emergency department visits/prednisone bursts in the last 12 months or at least 1 asthma related hospitalization in the last 12 months
• •requiring daily controller therapy with either inhaled corticosteroids or combination corticosteroids/long acting beta agonist (LABA).
• •Patients using metered dose inhaler therapy would be eligible. Patients may also be on leukotriene antagonists,
• •Must be made aware that they will have to read and accept to the terms of the User Agreement prior to enrollment in the study. If they do not agree they will not be able to continue participation. The User agreement will be read agreed to electronically when they begin using the device, however a paper version will be provided at the time of consent upon request.